Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, announced that Dennis Dionne (age 66), Executive Director for Commercial...
read more
Medivir AB has announced that the acquisitions of the two clinical stage oncology programs from TetraLogic Pharmaceuticals Corporation have been completed.
read more
Wednesday, January 04, 2017
Aptuit and Chiesi Farmaceutici have entered an agreement under which Aptuit will conduct an integrated Discovery Project aimed at providing innovative drugs to treat Idiopathic Pulmonary Fibrosis.
read more
Wednesday, January 04, 2017
Bruker has announced the acquisition of InVivo Biotech Services GmbH, headquartered in Hennigsdorf, Germany, near Berlin. InVivo Biotech is a molecular biology contract manufacturing organization (CMO), and a leading provider of monoclonal antibodies...
read more
Wednesday, January 04, 2017
MilliporeSigma has acquired BioControl Systems Inc., a provider of food safety testing. The acquisition opens growth opportunities for MilliporeSigma in the food and beverage space, particularly in the U.S. Confidentiality has been agreed on the ...
read more
Wednesday, January 04, 2017
Rinchem Company Inc., announces the opening of a new facility in the Atlanta metro area. The warehouse, located at 3195 N. Lanier Parkway in Decatur, Georgia, has 80,000 square feet of storage space.
read more
Wednesday, January 04, 2017
The PolyPeptide Group announced that the acquisition of the peptides business and operations of Lonza in Braine-l'Alleud, Belgium has been completed. The Braine facility, with approximately 280 employees, was the center for peptide chemical ...
read more
Wednesday, January 04, 2017
Custopharm, Inc. has acquired two paragraph IV abbreviated new drug application (ANDA) products from Perrigo Company.
read more
Thursday, January 05, 2017
TrialScope, a provider of managed compliance solutions for clinical trial disclosure, has announced that the Board of Directors appointed Mark Heinold as chief executive officer.
read more
Thursday, January 05, 2017
WuXi NextCODE, the contract genomics organization enabling precision medicine worldwide, and the National Heart Centre Singapore (NHCS), a leading national and regional cardiovascular medicine center, today announced their partnership to advance ...
read more
Metabolon, Inc. has entered into an agreement with InnVentis Ltd. to apply metabolomics in individuals with chronic inflammatory diseases, such as rheumatoid arthritis. InnVentis aims to bring together multi-omics technologies with clinical data and ...
read more
Curis has exercised its option to extend the exclusivity period with Aurigene under the collaboration, license and option agreement established in January, 2015. As previously reported, the extension of exclusivity is associated with a payment of $7....
read more
Orchard Therapeutics, a clinical-stage biotechnology company dedicated to bringing transformative ex-vivo gene therapies to patients with serious and life-threatening orphan diseases has announced an alliance with PharmaCell B.V., a Contract ...
read more
EyeGate Pharmaceuticals has received an additional development milestone from a subsidiary of Valeant Pharmaceuticals International, Inc. under the Company’s License Agreement with Valeant, pursuant to which EyeGate has granted Valeant exclusive, ...
read more
Hammock Pharmaceuticals has announced the execution of a license agreement with MilanaPharm/TriLogic Pharma for the exclusive global rights to their women's health and urology hydrogel technology platform.
read more